Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 6, 2008, Pages 1576-1585

  Sternberg, David I ^a   Gowda, Ram ^a   Mehra, Divya ^a   Qu, Wu ^a   Weinberg, Alan ^a   Twaddell, William ^a   Sarkar, Joydeep ^a   Wallace, Allison ^a   Hudson, Barry ^a   D'Ovidio, Frank ^a   Arcasoy, Selim ^a   Ramasamy, Ravichandran ^a   D'Armiento, Jeanine ^a   Schmidt, Ann Marie ^a   Sonett, Joshua R ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; C57BL 6 MOUSE; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; FLUORESCENCE; HISTOPATHOLOGY; LUNG FLUID; LUNG FUNCTION; LUNG INJURY; LUNG PERFUSION; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN TENSION; PRIORITY JOURNAL; RECEPTOR BLOCKING; REPERFUSION; REPERFUSION INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; ISCHEMIA; LIGANDS; LUNG; LUNG DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; REPERFUSION INJURY;

EID: 57949107944     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.05.032     Document Type: Article

References (64)

1. Carter Y.M., and Davis R.D. Primary graft dysfunction in lung transplantation. Semin Respir Crit Care Med 27 (2006) 501-507
2. Trulock E.P., Christie J.D., Edwards L.B., Boucek M.M., Aurora P., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 26 (2007) 782-795
3. Christie J.D., Bavaria J.E., Palevsky H.I., Litzky L., Blumenthal N.P., Kaiser L.R., et al. Primary graft failure following lung transplantation. Chest 114 (1998) 51-60
4. Christie J.D., Kotloff R.M., Ahya V.N., Tino G., Pochettino A., Gaughan C., et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 171 (2005) 1312-1316
5. Christie J.D., Sager J.S., Kimmel S.E., Ahya V.N., Gaughan C., Blumenthal N.P., et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 127 (2005) 161-165
6. Whitson B.A., Prekker M.E., Herrington C.S., Whelan T.P., Radosevich D.M., Hertz M.I., et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant 26 (2007) 1004-1011
7. Wickersham N.E., Johnson J.J., Meyrick B.O., Gilroy R.J., and Loyd J.E. Lung ischemia-reperfusion injury in awake sheep: protection with verapamil. J Appl Physiol 71 (1991) 1554-1562
8. Thabut G., Vinatier I., Stern J.B., Lesèche G., Loirat P., Fournier M., et al. Primary graft failure following lung transplantation: predictive factors of mortality. Chest 121 (2002) 1876-1882
9. Khan S.U., Salloum J., O'Donovan P.B., Mascha E.J., Mehta A.C., Matthay M.A., et al. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 116 (1999) 187-194
10. Ovechkin A.V., Lominadze D., Sedoris K.C., Robinson T.W., Tyagi S.C., and Roberts A.M. Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 113 (2007) 1-12
11. Gilroy Jr. R.J., Bhatte M.J., Wickersham N.E., Pou N.A., Loyd J.E., and Overholser K.A. Postischemic hypoperfusion during unilateral lung reperfusion in vivo. Am Rev Respir Dis 147 (1993) 276-282
12. Miller D.L., and Roberts A.M. Pulmonary artery occlusion and reperfusion causes microvascular constriction in the rabbit lung. Ann Thorac Surg 67 (1999) 323-328
13. Uchida T., Shirasawa M., Ware L.B., Kojima K., Hata Y., Makita K., et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173 (2006) 1008-1015
14. Schmidt A.M., Yan S.D., Yan S.F., and Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108 (2001) 949-955
15. Herold K., Moser B., Chen Y., Zeng S., Yan S.F., Ramasamy R., et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 82 (2007) 204-212
16. Yan S.F., Naka Y., Hudson B.I., Herold K., Yan S.D., Ramasamy R., et al. The ligand/RAGE axis: lighting the fuse and igniting vascular stress. Curr Atheroscler Rep 8 (2006) 232-239
17. Brett J., Schmidt A.M., Yan S.D., Zou Y.S., Weidman E., Pinsky D., et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143 (1993) 1699-1712
18. Schmidt A.M., Yan S.D., and Stern D.M. The dark side of glucose. Nat Med 1 (1995) 1002-1004
19. Ramasamy R., Yan S.F., and Schmidt A.M. The RAGE Axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc Med 15 (2005) 237-243
20. Frank J.A., Briot R., Lee J.W., Ishizaka A., Uchida T., and Matthay M.A. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 293 (2007) L52-L59
21. Calfee C.S., Budev M.M., Matthay M.A., Church G., Brady S., Uchida T., et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transplant 26 (2007) 675-680
22. Park L., Raman K.G., Lee K.J., Lu Y., Ferran Jr. L.J., Chow W.S., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4 (1998) 1025-1031
23. Sakaguchi T., Yan S.F., Yan S.D., Belov D., Rong L.L., Sousa M., et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. J Clin Invest 111 (2003) 959-972
24. Ohmori S., Mori M., Kawase M., and Tsuboi S. Determination of methyl-glyoxal as 2-methylquinoxaline by high-performance liquid chromatography and its application to biological samples. J Chromatogr 414 (1987) 149-155
25. Bucciarelli L.G., Kaneko M., Ananthakrishnan R., Harja E., Lee L.K., Hwang Y.C., et al. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation 113 (2006) 1226-1234
26. Thornalley P. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy. General Pharmacology 27 (1996) 565-573
27. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., et al. Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Cell 124 (2006) 275-286
28. Shinohara M., Thornalley P., Giardino I., Beisswenger P., Thorpe S., Onorato J., et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101 (1998) 1142-1147
29. Schäfer B.W., and Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 21 (1996) 134-140
30. Wittkowski H., Sturrock A., van Zoelen M.A., Viemann D., van der Poll T., Hoidal J.R., et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 35 (2007) 1369-1375
31. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
32. De Perrot M., Sekine Y., Fischer S., Waddell T.K., McRae K., Liu M., et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165 (2002) 211-215
33. Watanabe K., Konishi K., Fujioka M., Kinoshita S., and Nakagawa H. The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem 264 (1989) 19559-19563
34. Van Damme J., Wuyts A., Froyen G., Van Coillie E., Struyf S., Billiau A., et al. Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage. J Leukoc Biol 62 (1997) 563-569
35. Gilmore T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25 (2006) 6680-6684
36. Ross S.D., Kron I.L., Gangemi J.J., Shockey K.S., Stoler M., Kern J.A., et al. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-kappaB. Am J Physiol Lung Cell Mol Physiol 279 (2000) L528-L536
37. Ng C.S., Wan S., Arifi A.A., and Yim A.P. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 36 (2006) 205-214
38. Naka Y., Chowdhury N.C., Oz M.C., Smith C.R., Yano O.J., Michler R.E., et al. Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant model. J Thorac Cardiovasc Surg 109 (1995) 206-210
39. Ogawa S Shreeniwas R., Brett J., Clauss M., Furie M., and Stern D.M. The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function. Br J Haematol 75 (1990) 517-524
40. Colombat M., Castier Y., Leseche G., Rufat P., Mal H., Thabut G., et al. Early expression of adhesion molecules after lung transplantation: evidence for a role of aggregated P-selectin-positive platelets in human primary graft failure. J Heart Lung Transplant 23 (2004) 1087-1092
41. Patel KD Zimmerman G.A., Prescott S.M., McEver R.P., and McIntyre T.M. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 112 (1991) 749-759
42. Ogawa S., Koga S., Kuwabara S., Brett J., Morrow B., Morris S.A., et al. Hypoxia induced increased permeability of endothelial monolayers occurs through lowering of cAMP levels. Am J Physiol 262 (1992) 546-554
43. Naka Y., Hirose H., Matsuda H., Shirakura R., Miyagawa S., Fukushima N., et al. Prevention of pulmonary edema developing in autoperfusing heart-lung preparation by leukocyte depletion. Eur J Cardiothorac Surg 3 (1989) 355-358
44. Levine A.J., Parkes K., Rooney S., and Bonser R.S. Reduction of endothelial injury after hypothermic lung preservation by initial leukocyte-depleted reperfusion. J Thorac Cardiovasc Surg 120 (2000) 47-54
45. Eppinger M.J., Deeb G.M., Bolling S.F., and Ward P.A. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 150 (1997) 1773-1784
46. Fujita T., Asai T., Andrassy M., Stern D.M., Pinsky D.J., Zou Y.S., et al. PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest 113 (2004) 1615-1623
47. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192 (2000) 565-570
48. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33 (2001) 637-668
49. Lander H.M., Tauras J.M., Ogiste J.S., Hori O., Moss R.A., and Schmidt A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272 (1997) 17810-17814
50. Huang J.S., Guh J.Y., Chen H.C., Hung W.C., Lai Y.H., and Chuang L.Y. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 81 (2001) 102-113
51. Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P.M., Chen J., et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50 (2001) 2792-2808
52. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
53. Goldin A., Beckman J.A., Schmidt A.M., and Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114 (2006) 597-605
54. Hanford L.E., Fattman C.L., Shaefer L.M., Enghild J.J., Valnickova Z., and Oury T.D. Regulation of receptor for advanced glycation end products during bleomycin-induced lung injury. Am J Respir Cell Mol Biol 29 suppl (2003) S77-S81
55. Lizotte P.P., Hanford L.E., Enghild J.J., Nozik-Grayck E., Giles B.L., and Oury T.D. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol 7 (2007) 15
56. Bartling B., Hofmann H.S., Weigle B., Silber R.E., and Simm A. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26 (2005) 293-301
57. Morbini P., Villa C., Campo I., Zorzetto M., Inghilleri S., and Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?. Mod Pathol 19 (2006) 1437-1445
58. Koyama H., Yamamoto H., and Nishizawa Y. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Mol Med 13 (2007) 625-635
59. Tan K.C., Shiu S.W., Chow W.S., Leng L., Bucala R., and Betteridge D.J. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 49 (2006) 2756-2762
60. Humpert P.M., Djuric Z., Kopf S., Rudofsky G., Morcos M., Nawroth P.P., et al. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes. Cardiovasc Diabetol 7 (2007) 9
61. Geroldi D., Falcone C., Minoretti P., Emanuele E., Arra M., and D'Angelo A. High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans. J Am Geriatr Soc 54 (2006) 1149-1150
62. Emanuele E., D'Angelo A., Tomaino C., Binetti G., Ghidoni R., Politi P., et al. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol 62 (2005) 1734-1736
63. Geroldi D., Falcone C., Emanuele E., D'Angelo A., Calcagnino M., Buzzi M.P., et al. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens 23 (2005) 1725-1729
64. Thornalley P.J. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 269 (1990) 1-11